Hospital
Mclaren Caro Region
Mclaren Caro Region was paid $5.78M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoMCLAREN CARO REGION
CARO, MI 48723
CARO, MI 48723
33aNPI1073568978assigned 05/23/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$5.78M
24GClaims134,845
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Michigan
Rank by total paid#5 of 8
Median peer was paid$5.78M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BARANSKI, KENNETH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,986 | $697K | |
| 2019 | 23,016 | $756K | |
| 2020 | 16,075 | $721K | |
| 2021 | 19,759 | $888K | |
| 2022 | 20,636 | $964K | |
| 2023 | 20,728 | $950K | |
| 2024incomplete | 16,645 | $799K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 10,647 | 10,066 | $1.71M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 6,297 | 5,802 | $1.38M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 2,852 | 2,678 | $948K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.5% | 2,927 | 2,703 | $316K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.0% | 2,284 | 2,220 | $229K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.6% | 4,821 | 4,368 | $207K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 1,988 | 1,882 | $134K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 2,383 | 2,143 | $89K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 2,053 | 2,000 | $87K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 2,205 | 676 | $58K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 578 | 575 | $50K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,300 | 1,163 | $41K |
100 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 464 | $40K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 229 | $39K |
| 71045 | Radiologic examination, chest; single view | <1% | 753 | $36K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 556 | $34K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,128 | $33K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 200 | $28K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,320 | $28K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 269 | $25K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 574 | $23K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 837 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,614 | $19K |
| 80061 | Lipid panel | <1% | 3,043 | $19K |
| 80053 | Comprehensive metabolic panel | <1% | 8,662 | $18K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 415 | $17K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,455 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,143 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 163 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 385 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,186 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,422 | $7K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 102 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,130 | $7K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 68 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,291 | $5K |
| 84439 | <1% | 1,263 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,848 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,880 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 347 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 107 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 28 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 151 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,262 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 23 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 189 | $2K |
| 83735 | <1% | 1,669 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 149 | $2K |
| 82607 | <1% | 272 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 59 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 564 | $2K |
| 85027 | <1% | 1,156 | $2K | |
| 73130 | <1% | 131 | $1K | |
| 85610 | <1% | 1,950 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 392 | $971.41 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $932.78 |
| 97161 | <1% | 13 | $909.19 | |
| 99441 | <1% | 103 | $755.27 | |
| 73630 | <1% | 85 | $688.79 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 909 | $581.21 |
| 87070 | <1% | 579 | $567.93 | |
| 99442 | <1% | 38 | $550.45 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 77 | $549.49 |
| 73610 | <1% | 59 | $463.32 | |
| 81025 | <1% | 2,185 | $446.16 | |
| 81001 | <1% | 3,046 | $431.74 | |
| 87077 | <1% | 171 | $360.41 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 376 | $342.48 |
| 81002 | <1% | 168 | $339.09 | |
| 83690 | <1% | 2,123 | $310.91 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,578 | $306.33 |
| 87186 | <1% | 92 | $296.23 | |
| 81003 | <1% | 1,686 | $286.39 | |
| 73564 | <1% | 12 | $280.41 | |
| 73030 | <1% | 12 | $261.36 | |
| 90686 | <1% | 16 | $241.69 | |
| 85730 | <1% | 855 | $226.43 | |
| 80076 | <1% | 54 | $218.94 | |
| 84484 | <1% | 1,200 | $200.03 | |
| 85007 | <1% | 265 | $152.51 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $152.24 |
| 82150 | <1% | 802 | $135.04 | |
| 83540 | <1% | 40 | $110.14 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $99.19 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $99.19 |
| 84481 | <1% | 13 | $82.49 | |
| 87807 | <1% | 39 | $56.03 | |
| 82043 | <1% | 12 | $46.14 | |
| 86140 | <1% | 28 | $45.39 | |
| 83605 | <1% | 2,302 | $41.47 | |
| 82728 | <1% | 12 | $38.23 | |
| 90715 | <1% | 12 | $35.65 | |
| 84100 | <1% | 64 | $30.28 | |
| 82248 | <1% | 13 | $20.32 | |
| 85379 | <1% | 25 | $6.44 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 57 | $6.00 |
| 74022 | <1% | 12 | $4.55 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,758 | $1.03 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 261 | $0.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 672 | $0.44 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 93 | $0.00 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 176 | $0.00 |
| J3490 | Unclassified drugs | 0% | 795 | $0.00 |
| 87430 | 0% | 358 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 61 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 49 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 124 | $0.00 |
| 87040 | 0% | 15 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 355 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 731 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARANSKI, KENNETH (CFO)
| Provider | Location | Paid |
|---|---|---|
| Mclaren Thumb Region | Bad Axe, MI | $4.97M |
| Mclaren Thumb Region | Bad Axe, MI | $1.57M |
| General John J Pershing Memorial Hospital Association | Brookfield, MO | $913K |
| Hills & Dales General Hospital, INC. | Kingston, MI | $603K |
| General John J Pershing Memorial Hospital Association | Brookfield, MO | $588K |
| Hills & Dales General Hospital, INC. | Cass City, MI | $491K |
| Hills & Dales General Hospital, INC. | Cass City, MI | $478K |
| Mclaren Thumb Region | Bad Axe, MI | $385K |
| General John J Pershing Memorial Hospital Association | Brookfield, MO | $251K |
| Hills & Dales General Hospital, INC. | Cass City, MI | $231K |
| Mclaren Thumb Region | Bad Axe, MI | $207K |
| Mclaren Thumb Region | Bad Axe, MI | $154K |
| Hills & Dales General Hospital, INC. | Ubly, MI | $146K |
| Mclaren Thumb Region | Ubly, MI | $120K |
| Mclaren Caro Region | Caro, MI | $99K |
| General John J Pershing Memorial Hospital Association | Brookfield, MO | $86K |
| Mclaren Caro Region | Caro, MI | $75K |
| Mclaren Thumb Region | Bad Axe, MI | $71K |
| Mclaren Caro Region | Caro, MI | $51K |
| Mclaren Caro Region | Vassar, MI | $49K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.